Concepedia

Kelly A. Wong

KA

Statistics

Publications

17

Citations

1.2K

H-Index

15

Active since

2004

Affiliations

Gilead Sciences (United States)(Current)

University of California, Los Angeles

Howard Hughes Medical Institute

Novartis (United States)

Seno Medical (United States)

Kelly A. Wong is an author at Gilead Sciences (United States) specializing in viral hepatitis, antiviral therapy, and molecular virology.

ORCID

Publications per year

2004–2024

17

Publications

17

PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity

Bin Liu, Sheldon Mink, Kelly A. Wong et al. · Nature Immunology · 2004 · 266 citations

, , +14

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C

Eric Lawitz, Daniel Gruener, John M. Hill et al. · Journal of Hepatology · 2012 · 158 citations

, , +11

Negative Regulation of NF-κB Signaling by PIAS1

Bin Liu, Randy Yang, Kelly A. Wong et al. · Molecular and Cellular Biology · 2005 · 148 citations · Full text

, , +14

Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885

Kelly A. Wong, Angela Worth, Ross Martin et al. · Antimicrobial Agents and Chemotherapy · 2013 · 95 citations · Full text

, , +17

Protein Inhibitor of Activated STAT Y (PIASy) and a Splice Variant Lacking Exon 6 Enhance Sumoylation but Are Not Essential for Embryogenesis and Adult Life

Kelly A. Wong, Rachel Kim, Heather R. Christofk et al. · Molecular and Cellular Biology · 2004 · 91 citations · Full text

, , +10

1–5 of 17